"INVESTIGATION OF RELATIONSHIP BETWEEN INTERLEUKIN (IL)-18 GENE POLYMORPHISMS (RS187238, RS1946518 AND RS1946519) AND MULTIPLE SCLEROSIS DISEASE"


Creative Commons License

Arman A.

8TH INTERNATIONAL "BAŞKENT" CONGRESS ON MEDICINE, NURSING, AND HEALTH SCIENCES, Ankara, Türkiye, 4 - 06 Şubat 2023, ss.237, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Ankara
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.237
  • Marmara Üniversitesi Adresli: Evet

Özet

Investigation of the relationship between interleukin (IL)-18 gene polymorphisms (rs187238, rs1946518 and rs1946519) and Multiple Sclerosis disease

 

Student Name: EDANUR ÇAKMAK

 

Name of Supervisor: PROF.DR. AHMET ARMAN

 

Objective: Multiple Sclerosis is defined as a complex disease thought to be caused by genetic and non-genetic factors. In this study, it was aimed to determine whether there is a relationship between MS disease and rs1946518, rs1946519 and rs187238 polymorphisms of IL-18 in the Turkish population.

 

Material and methods: AS-PCR method was used for rs187238 single nucleotide polymorphism, and RFLP method using restriction cutting enzymes was used for rs1946518 and rs1946519 polymorphisms. Imaging of PCR results was done by agarose gel electrophoresis. The obtained data were evaluated statistically.

 

Results: The relationship between polymorphisms and MS was investigated by chi-square test. Values ​​with a P value less than 0.05 were considered statistically significant. The p value was calculated as 0.001 for the 137G>C polymorphism, the p value was less than 0.001 for the 607C>A polymorphism, and the p value was calculated as 0.1 for the 656 G>T polymorphism. As a result, a significant relationship was found for 137G>C, 607C>A polymorphisms. No significant relationship was found for the 656 G>T polymorphism.

 

Conclusion: Investigating the relationship between MS disease and IL18 gene polymorphism provides a better understanding of the pathogenesis and genetic background of the disease, and contributes to target therapies that can be developed in the future.

 

Keywords: Multiple Sclerosis, polymorphism, IL-18, genetics